Search results
Results From The WOW.Com Content Network
The Quality of Life of Carers of Alzheimer's Disease Patients (ACQLI) is a measure which assesses the quality of life of people who care for Alzheimer's disease patients. It was developed in 1997 by Galen Research [1] and has been used in studies investigating rosiglitazone [2] [3] [4] and the effects of pharmacological treatment. [5] Angina.
The Quality of Life In Depression Scale (QLDS), originally proposed by Sonja Hunt and Stephen McKenna, is a disease specific patient-reported outcome which assesses the impact that depression has on a patient's quality of life. [1] It is the most commonly used measure of quality of life in clinical trials and studies of depression. [2]
The self-perceived quality-of-life scale [1] [2] is a psychological assessment instrument which is based on a comprehensive theory of the self-perceived quality of life (SPQL) [3] and provides a multi-faceted measurement of health-related and non-health-related aspects of well-being. [4]
The Quality of Well-Being Scale (QWB) is a general health quality of life questionnaire which measures overall status and well-being over the previous three days in four areas: physical activities, social activities, mobility, and symptom/problem complexes. [1] It consists of 71 items and takes 20 minutes to complete. [2]
The Health Utilities Index (HUI) is a rating scale used to measure general health status and health-related quality of life (HRQoL). HUI questionnaires are designed to map onto two classification systems, HUI-2 and HUI-3, capable of measuring 24,000 and 972,000 unique health states, respectively.
The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status and an abbreviated variant of it, the SF-6D, is commonly used in health economics as a variable in the quality-adjusted life year calculation to determine the cost-effectiveness of a health treatment.
For example, it has been used to assess novel drugs, [37] models of clinical care, in audit of clinical services and in assessment of teledermatology. [36] The DLQI is the most widely used quality of life outcome measure in randomised controlled trials of therapies for psoriasis. [38]
It was the first patient completed quality of life questionnaire that focused on rheumatoid arthritis [6] and is distinct from other questionnaires as it includes physical contact as a dimension of quality of life. [3] Other dimensions include activities of daily living, social interaction/function, emotions, mood and recreation and pastimes. [7]